The European Medicines Agency (EMA), an agency of the European Union in charge of the scientific evaluation, supervision and safety monitoring of medicines for use in the EU, has published a position statement on the Zika virus and plasma-derived products.
The EMA has confirmed that there is no increased risk of contamination with the Zika virus for patients who take plasma-derived medicines.
Attached, you will find IPOPI’s Position Statement on the Zika virus reviewed, so as to include this last information.